| Corporate Overview
Founded in 1987, Aspect Medical System’s (NASDAQ: ASPM) mission was to develop
technology that could measure a then unknown element of patient status –
the direct effect of drugs and disease on the brain. Today, Aspect is recognized
as a pioneer and global market leader in brain monitoring, having led the way
to develop proprietary technologies that directly measure these effects and ultimately
improve the quality and cost effectiveness of patient care.
Aspect’s premier product — Bispectral Index™ (BIS™) technology
—became the first clinically p... More >> |  | | | 11/13/09 | Aspect Medical Systems announces offer to repurchase all outstanding 2.50% Convertible Senior Notes due 2014| Click Here to read this article... |
|  | | 10/19/09 | Aspect Medical Systems Features Anesthesia Outcomes Research, New Products at American Society of Anesthesiologists Annual Meeting| NORWOOD, Mass.--(BUSINESS WIRE)--Oct. 19, 2009--
The American Society of Anesthesiologists (ASA) Annual Meeting will
feature 62 scientific presentations that reference BIS® monitoring when
it convenes on October 17-21, 2009 in New Orleans. BIS-related research
will cover a broad range of applications for BIS monitoring, including
initial results from studies conducted as part of a comparative
effectiveness research collaboration with the Cleveland Cl... |
| | | 09/28/09 | Covidien Announces Definitive Agreement to Acquire Aspect Medical Systems, Inc.| DUBLIN, Ireland & NORWOOD, Mass., Sep 28, 2009 (BUSINESS WIRE) -- Covidien (NYSE: COV) and Aspect Medical Systems, Inc. (NASDAQ: ASPM)
today announced that Covidien has reached a definitive agreement to
acquire Aspect, a global market leader in brain monitoring technology.
The Boards of Directors of both companies have unanimously approved the
transaction, pursuant to which a wholly owned subsidiary of Covidien
will pay $12.00 in cash per Aspect share for a total... |
| | | 09/11/09 | Aspect Medical Systems Announces Publication of BRITE-MD Trial Results in Psychiatry Research|
-Trial demonstrates use of Aspect’s EEG-based biomarker as an early
indicator of antidepressant treatment efficacy with potential to help
guide depression care-
NORWOOD, Mass.--(BUSINESS WIRE)--Sep. 11, 2009--
Aspect
Medical Systems, Inc. (NASDAQ: ASPM) today announced that two
companion articles highlighting results from the BRITE-MD (Biomarkers
for Rapid Identification of Treatment Effectiveness trial in Major
Depression) were... |
| |
|
|
| 07/29/09 | | | 04/29/09 | | | 02/05/09 | | | 10/29/08 | | | 07/24/08 | | | 04/17/08 | | | 02/07/08 | | | 10/24/07 | | | 07/25/07 | | | 04/25/07 | |
|
| There are currently no events scheduled. |
Receive E-mail Alerts | | Sign up to receive e-mail alerts whenever Aspect Medical Systems posts new information to the site. Just enter your e-mail address and click Submit. |
|
|
